This is our Regulatory Landscape newsletter for April 2025 with our monthly insights on the evolving market for Regulatory professionals.
For the month of March there were approximately 86 new Regulatory positions posted at smaller biopharma companies in the US. This is up about 3% from February but down 8.5% from what we saw in March 2024.
66% of these new positions in March were in Clinical Regulatory Strategy and 22% were in CMC Regulatory, 8% were in Advertising, Promotions & Labeling, and 3% in Regulatory Operations. Roughly 62% of these roles were at Director level and above. There were only six new Regulatory VP/SVP positions posted in March.
49% of the new Regulatory positions in March were listed as Onsite, 29% were posted as Remote and 22% were Hybrid (remote/onsite). 29% of the March Regulatory positions were in California, 30% were in Massachusetts, and 20% were in the NJ/NY/PA area.
There were layoffs announced at 26 biotech and pharma companies in March.
This month we are working on the following searches for our clients:
- Vice President of Regulatory Affairs – Oncology (Hybrid, Boston Area)
- Regulatory Affairs Executive Director – Ophthalmics (Hybrid, Boston area)
- Regulatory Affairs Sr Director or Exec Director – Rare Disease (Remote)
- Regulatory Advertising & Promotions Associate Director (Boston or Philly areas)
- Senior Regulatory Affairs Consultant – Oncology (SF Bay Area)
You can view job descriptions for each of these on our site at https://dennispartners.com/
Please consider us for your Regulatory hiring or let us know if you are considering a career change soon.